Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$61.07
0.000.00%
Pre-Market: 4:01 PM EDT
Comments
Loading...
Bio-Techne Analyst Ratings and Price Targets | NASDAQ:TECH | Benzinga
Bio-Techne Corp has a consensus price target of $108.47 based on the ratings of 16 analysts. The high is $465 issued by Credit Suisse on August 25, 2022. The low is $65 issued by Stifel on February 2, 2024. The 3 most-recent analyst ratings were released by Evercore ISI Group, Citigroup, and Baird on March 18, 2025, March 4, 2025, and February 19, 2025, respectively. With an average price target of $71 between Evercore ISI Group, Citigroup, and Baird, there's an implied 16.26% upside for Bio-Techne Corp from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Evercore ISI Group
Citigroup
Baird
RBC Capital
Scotiabank
1calculated from analyst ratings
Analyst Ratings for Bio-Techne
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 03/18/2025 | Buy Now | 22.81% | Evercore ISI Group | Daniel Markowitz16% | → $75 | Initiates | → Outperform | Get Alert |
| 03/04/2025 | Buy Now | 14.62% | Citigroup | Patrick Donnelly80% | $80 → $70 | Maintains | Neutral | Get Alert |
| 02/19/2025 | Buy Now | 11.35% | Baird | Catherine Schulte68% | $88 → $68 | Downgrade | Outperform → Neutral | Get Alert |
| 02/06/2025 | Buy Now | 31% | RBC Capital | Conor McNamara35% | $79 → $80 | Maintains | Sector Perform | Get Alert |
| 02/06/2025 | Buy Now | 47.37% | Scotiabank | Sung Ji Nam46% | $88 → $90 | Maintains | Sector Outperform | Get Alert |
| 02/06/2025 | Buy Now | 47.37% | Keybanc | John Vinh72% | $80 → $90 | Maintains | Overweight | Get Alert |
| 10/31/2024 | Buy Now | 44.1% | Scotiabank | Sung Ji Nam46% | $83 → $88 | Maintains | Sector Outperform | Get Alert |
| 10/31/2024 | Buy Now | 37.55% | Baird | Catherine Schulte68% | $82 → $84 | Maintains | Outperform | Get Alert |
| 08/13/2024 | Buy Now | 55.56% | Benchmark | Robert Wasserman50% | $95 → $95 | Reiterates | Buy → Buy | Get Alert |
| 08/08/2024 | Buy Now | 14.62% | RBC Capital | Conor McNamara35% | $72 → $70 | Maintains | Sector Perform | Get Alert |
| 08/08/2024 | Buy Now | 34.27% | Baird | Catherine Schulte68% | $81 → $82 | Maintains | Outperform | Get Alert |
| 05/22/2024 | Buy Now | 39.18% | Citigroup | Patrick Donnelly80% | → $85 | Downgrade | Buy → Neutral | Get Alert |
| 05/02/2024 | Buy Now | 55.56% | Benchmark | Robert Wasserman50% | $95 → $95 | Reiterates | Buy → Buy | Get Alert |
| 05/02/2024 | Buy Now | 32.63% | Baird | Catherine Schulte68% | $73 → $81 | Maintains | Outperform | Get Alert |
| 04/18/2024 | Buy Now | 34.27% | Deutsche Bank | Justin Bowers50% | $85 → $82 | Maintains | Buy | Get Alert |
| 02/02/2024 | Buy Now | 6.44% | Stifel | Daniel Arias66% | → $65 | Downgrade | Buy → Hold | Get Alert |
| 02/02/2024 | Buy Now | 42.46% | Stephens & Co. | Jacob Johnson57% | $92 → $87 | Maintains | Overweight | Get Alert |
| 02/02/2024 | Buy Now | 22.81% | RBC Capital | Conor McNamara35% | $85 → $75 | Maintains | Sector Perform | Get Alert |
| 12/07/2023 | Buy Now | 31% | UBS | Dan Leonard55% | → $80 | Initiates | → Buy | Get Alert |
| 11/02/2023 | Buy Now | 6.44% | Stifel | Daniel Arias66% | $104 → $65 | Maintains | Buy | Get Alert |
| 11/01/2023 | Buy Now | 31% | Citigroup | Patrick Donnelly80% | $100 → $80 | Maintains | Buy | Get Alert |
| 11/01/2023 | Buy Now | 35.91% | RBC Capital | Conor McNamara35% | $85 → $83 | Maintains | Sector Perform | Get Alert |
| 11/01/2023 | Buy Now | 31% | Keybanc | Paul Knight53% | $115 → $80 | Maintains | Overweight | Get Alert |
| 09/12/2023 | Buy Now | 40.82% | RBC Capital | Conor McNamara35% | → $86 | Reiterates | Sector Perform → Sector Perform | Get Alert |
| 08/28/2023 | Buy Now | — | William Blair | Matt Larew25% | — | Initiates | → Outperform | Get Alert |
| 08/18/2023 | Buy Now | 96.5% | Benchmark | Robert Wasserman50% | → $120 | Reiterates | Buy → Buy | Get Alert |
| 08/09/2023 | Buy Now | 63.75% | Stephens & Co. | Jacob Johnson57% | → $100 | Reiterates | Overweight → Overweight | Get Alert |
| 05/04/2023 | Buy Now | 47.37% | RBC Capital | Conor McNamara35% | $89 → $90 | Maintains | Sector Perform | Get Alert |
| 05/04/2023 | Buy Now | 63.75% | Stephens & Co. | Jacob Johnson57% | → $100 | Reiterates | → Overweight | Get Alert |
| 05/04/2023 | Buy Now | 63.75% | Baird | Catherine Schulte68% | $99 → $100 | Maintains | Outperform | Get Alert |
| 02/06/2023 | Buy Now | 44.1% | RBC Capital | Conor McNamara35% | $89 → $88 | Maintains | Sector Perform | Get Alert |
| 02/03/2023 | Buy Now | 96.5% | Benchmark | Robert Wasserman50% | → $120 | Maintains | Buy | Get Alert |
| 02/03/2023 | Buy Now | 80.12% | SVB Leerink | Puneet Souda56% | $125 → $110 | Maintains | Outperform | Get Alert |
| 02/03/2023 | Buy Now | 88.31% | Keybanc | Paul Knight53% | $125 → $115 | Maintains | Overweight | Get Alert |
| 01/10/2023 | Buy Now | 47.37% | Wells Fargo | Timothy Daley52% | → $90 | Upgrade | Underweight → Equal-Weight | Get Alert |
| 12/14/2022 | Buy Now | 63.75% | Deutsche Bank | Justin Bowers50% | → $100 | Initiates | → Buy | Get Alert |
| 12/12/2022 | Buy Now | 63.75% | Citigroup | Patrick Donnelly80% | $81.25 → $100 | Upgrade | Neutral → Buy | Get Alert |
| 12/07/2022 | Buy Now | 45.73% | RBC Capital | Conor McNamara35% | → $89 | Initiates | → Sector Perform | Get Alert |
| 12/05/2022 | Buy Now | 71.93% | Stephens & Co. | Jacob Johnson57% | $420 → $105 | Maintains | Overweight | Get Alert |
| 11/02/2022 | Buy Now | 718.73% | SVB Leerink | Puneet Souda56% | $137.5 → $125 | Maintains | Outperform | Get Alert |
| 08/25/2022 | Buy Now | 661.42% | Credit Suisse | Dan Leonard55% | → $116.25 | Initiates | → Outperform | Get Alert |
| 08/16/2022 | Buy Now | 489.49% | Wells Fargo | Timothy Daley52% | $92.5 → $90 | Maintains | Underweight | Get Alert |
| 08/05/2022 | Buy Now | 685.98% | Stephens & Co. | Jacob Johnson57% | $125 → $120 | Maintains | Overweight | Get Alert |
| 05/05/2022 | Buy Now | 718.73% | Keybanc | Paul Knight53% | $150 → $125 | Maintains | Overweight | Get Alert |
| 04/25/2022 | Buy Now | 505.86% | Wells Fargo | Timothy Daley52% | $100 → $92.5 | Downgrade | Equal-Weight → Underweight | Get Alert |
FAQ
What is the target price for Bio-Techne (TECH) stock?
The latest price target for Bio-Techne (NASDAQ:TECH) was reported by Evercore ISI Group on March 18, 2025. The analyst firm set a price target for $75.00 expecting TECH to rise to within 12 months (a possible 22.81% upside). 15 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Bio-Techne (TECH)?
The latest analyst rating for Bio-Techne (NASDAQ:TECH) was provided by Evercore ISI Group, and Bio-Techne initiated their outperform rating.
When was the last upgrade for Bio-Techne (TECH)?
The last upgrade for Bio-Techne Corp happened on January 10, 2023 when Wells Fargo raised their price target to $90. Wells Fargo previously had an underweight for Bio-Techne Corp.
When was the last downgrade for Bio-Techne (TECH)?
The last downgrade for Bio-Techne Corp happened on February 19, 2025 when Baird changed their price target from $88 to $68 for Bio-Techne Corp.
When is the next analyst rating going to be posted or updated for Bio-Techne (TECH)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Bio-Techne, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Bio-Techne was filed on March 18, 2025 so you should expect the next rating to be made available sometime around March 18, 2026.
Is the Analyst Rating Bio-Techne (TECH) correct?
While ratings are subjective and will change, the latest Bio-Techne (TECH) rating was a initiated with a price target of $0.00 to $75.00. The current price Bio-Techne (TECH) is trading at is $61.07, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.